Eledon Pharmaceuticals

ELDNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$284.823 M

$3.69 +6.65%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$45.6M

Loss-making

Shares outstanding

75,851,722

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#241Natures Sunshine ProductsNATR$288.0M
#242CellectisCLLS$285.0M
#243Eledon PharmaceuticalsELDN$284.8M
#244Alx OncologyALXO$282.6M
#245Veraxa BiotechVRXA$281.4M

Where these numbers come from

Share counts and financials for Eledon Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.